Table II.
Association between SPOPL and the clinicopathological characteristics of patients with MB.
| SPOPL | |||
|---|---|---|---|
| Characteristic | Low or none | High | χ2 (P-value) |
| Age, years | |||
| ≤3 | 4 | 1 | 0.821 |
| >3 | 40 | 13 | |
| Sex | |||
| Male | 34 | 12 | 0.764 |
| Female | 10 | 2 | |
| WHO histological subtype | |||
| Classic | 34 | 10 | 0.931 |
| Desmoplastic | 10 | 4 | |
| Residual tumor size, cm2 | |||
| <1.5 | 41 | 14 | 0.756 |
| ≥1.5 | 3 | 0 | |
| Metastatic status | |||
| M0 | 19 | 6 | 0.983 |
| M1 | 25 | 8 | |
| Tumor risk | |||
| Standard | 16 | 5 | 0.965 |
| High | 28 | 9 | |
| Differentiation level | |||
| Undifferentiated | 10 | 9 | 0.011 |
| Differentiated | 34 | 5 | |
WHO, World Health Organization; SPOPL, Speckle-type POZ protein-like.